“pfizer” Archives

in
Entry Author Date Location
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work 03/17/17 San Francisco
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
How Boragen Banked $10M to Develop New Boron-Based Fungicides 03/06/17 Raleigh Durham
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Report: Biotech VCs Perpetuate Boardroom Gender Gap 01/24/17 National
Cytori Buys San Antonio-based Azaya’s Drug Delivery Tech for Stock 01/19/17 Texas
Takeda, Maverick Therapeutics Enter $125M Cancer Therapy Partnership 01/11/17 San Francisco
Allergan, Eying More Neurodegenerative Drugs, Gets Right to Buy LTI 01/09/17 Boston
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug 12/19/16 Boulder/Denver
Boston Holiday Tech Watch: GiveHope, LovePop, Samsung, IBM & More 12/02/16 Boston
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
With New Data, Medicines Co. Takes Long-Lasting Heart Drug to Phase 3 11/15/16 New York
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
Weeks After Deal, FDA Slaps Clinical Hold on Regeneron/Teva Pain Drug 10/17/16 New York
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial 09/23/16 San Diego
With Tobira Deal, Allergan Keeps Shopping For “Questionable” Assets 09/20/16 San Francisco
Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva 09/20/16 New York
Pharmaceutical Price Controls Might Be Closer Than You Think 09/20/16 San Diego
Page 1 of 25 next page »